Adial Pharmaceuticals, Inc. Gains (Losses) on Restructuring of Debt
Adial Pharmaceuticals, Inc. (ADIL) reported Gains (Losses) on Restructuring of Debt of $29.09 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnRestructuringOfDebt · last filed 2023-03-30
- Adial Pharmaceuticals, Inc. gains (losses) on restructuring of debt for the quarter ending 2021-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. gains (losses) on restructuring of debt for the quarter ending 2021-09-30 was $0.00.
- Adial Pharmaceuticals, Inc. gains (losses) on restructuring of debt for fiscal 2021 was $29.09K.
| Period end | Gains (Losses) on Restructuring of Debt 3 month | Gains (Losses) on Restructuring of Debt 6 month | Gains (Losses) on Restructuring of Debt 9 month | Gains (Losses) on Restructuring of Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $29.09K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $29.09K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $29.09K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |